Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
32.41
+1.09 (3.48%)
Oct 19, 2026, 10:00 AM EDT - Market open
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Agios Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $46. The average 1-year stock price forecast is 41.93% higher than the current stock price, while the lowest is $32 (-1.27%) and the highest is $73 (+125.24%).
Price Target: $46 (+41.93%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $32 | Hold | Maintains | $32 | -1.27% | Oct 9, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $39 → $37 | Buy | Maintains | $39 → $37 | +14.16% | Oct 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $50 | Buy | Maintains | $50 | +54.27% | Oct 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 4, 2026 |
| Citi | Citi | Buy Maintains $46 → $52 | Buy | Maintains | $46 → $52 | +60.44% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
178.01M
from 54.03M
Increased by 229.47%
Revenue Next Year
347.08M
from 178.01M
Increased by 94.99%
EPS This Year
-5.72
from -7.12
EPS Next Year
-4.02
from -5.72
EPS and Forward PE are based on non-GAAP adjusted numbers.